tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Hiraoka A et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. 2001 Bone Marrow Transplant. pmid:11509936
McAlister VC et al. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. 2001 Liver Transpl. pmid:11510015
Terui T et al. Production and pharmacologic modulation of the granulocyte-associated allergic responses to ovalbumin in murine skin models induced by injecting ovalbumin-specific Th1 or Th2 cells. 2001 J. Invest. Dermatol. pmid:11511299
Tatekawa Y et al. Intragraft expression of p38 and activated p38 MAPK (mitogen-activated protein kinase) in rat small bowel transplantation. 2001 Transpl. Int. pmid:11512052
Hochleitner BW et al. Increased tacrolimus levels during diarrhea. 2001 Transpl. Int. pmid:11512055
Marx SO and Marks AR Bench to bedside: the development of rapamycin and its application to stent restenosis. 2001 Circulation pmid:11514367
Hiraga K et al. A novel screening for inhibitors of a pleiotropic drug resistant pump, Pdr5, in Saccharomyces cerevisiae. 2001 Biosci. Biotechnol. Biochem. pmid:11515543
Taupin JL et al. Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene. 2001 J. Immunol. Methods pmid:11516757
Cole O et al. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model. 2001 Ann R Coll Surg Engl pmid:11518369
Suzuki K et al. FK506 facilitates chemical kindling induced by pentylenetetrazole in rats. 2001 Epilepsy Res. pmid:11518629
Hashida T and Inui K [Therapeutic drug monitoring of immunosuppresants]. 2001 Rinsho Byori pmid:11519126
Morioka M et al. Intravenously injected FK506 failed to inhibit hippocampal calcineurin. 2001 Biochem. Biophys. Res. Commun. pmid:11520068
Dmitrewski J et al. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation. 2001 Diabetes Obes Metab pmid:11520309
Behrend M Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. 2001 Drug Saf pmid:11522119
Staatz C et al. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. 2001 Nephrol. Dial. Transplant. pmid:11522877
Anneser JM et al. Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice. 2001 Neuroreport pmid:11522944
Lhoëst G et al. In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry. 2001 J Mass Spectrom pmid:11523088
Szabo G et al. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. 2001 J. Investig. Med. pmid:11523700
Abu-Elmagd K et al. Clinical intestinal transplantation: a decade of experience at a single center. 2001 Ann. Surg. pmid:11524593
Riboldi-Tunnicliffe A et al. Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. 2001 Nat. Struct. Biol. pmid:11524681
Freyschmidt-Paul P et al. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus). 2001 Sep-Oct Eur J Dermatol pmid:11525945
Tremblay JP and Vilquin JT [Transplantation of normal or genetically modified myoblasts for the treatment of hereditary or acquired diseases]. 2001 J. Soc. Biol. pmid:11530497
Ikegame K et al. Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation. 2001 Int. J. Hematol. pmid:11530814
Elinav H et al. Plasma oxidizability and plasma carbonyls, markers of oxidative stress, in liver transplant patients. 2001 Transplant. Proc. pmid:11543789
Mor E et al. Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. 2001 Transplant. Proc. pmid:11543802
Weinbroum AA et al. Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. 2001 Transplant. Proc. pmid:11543812
Kovalev GI et al. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. 2001 J. Immunol. pmid:11544316
Berg UB et al. Renal function before and long after liver transplantation in children. 2001 Transplantation pmid:11544422
Aw MM et al. Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients. 2001 Transplantation pmid:11544444
Mann J Natural products as immunosuppressive agents. 2001 Nat Prod Rep pmid:11548050
Furukawa M et al. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. 2001 Neuroradiology pmid:11548166
Lübbe J Topical tacrolimus for atopic dermatitis: euphoria and vigilance. 2001 Dermatology (Basel) pmid:11549790
Kawakami T et al. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation. 2001 Dermatology (Basel) pmid:11549797
Aker S et al. Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells. 2001 Exp. Nephrol. pmid:11549851
Moody BR and Sengelmann RD Topical tacrolimus in the treatment of bovine collagen hypersensitivity. 2001 Dermatol Surg pmid:11553165
Dunn SE et al. Nerve activity-dependent modulation of calcineurin signaling in adult fast and slow skeletal muscle fibers. 2001 J. Biol. Chem. pmid:11555650
Carmody M et al. FKBP12 associates tightly with the skeletal muscle type 1 ryanodine receptor, but not with other intracellular calcium release channels. 2001 FEBS Lett. pmid:11557049
Schlitt HJ et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. 2001 Lancet pmid:11558484
Stewart SF et al. Mycophenolate mofetil monotherapy in liver transplantation. 2001 Lancet pmid:11558493
Choi CJ and Nghiem P Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. 2001 Arch Dermatol pmid:11559218
Cacciarelli TV et al. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. 2001 Pediatr Transplant pmid:11560756
Letko E et al. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506). 2001 Graefes Arch. Clin. Exp. Ophthalmol. pmid:11561793
Laham G et al. [Acute peripheral demyelinating polyneuropathy and acute renal failure after administration of FK506]. 2001 Medicina (B Aires) pmid:11563175
Briggs WA et al. Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid. 1999 J Clin Pharmacol pmid:11563403
Nakao A et al. Impact of tacrolimus and bone marrow augmentation on intestinal allograft survival and intragraft cytokine expression in rats. 2001 J Med pmid:11563819
Sindhi R et al. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. 2001 Transplantation pmid:11571449
Takamatsu Y et al. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. 2001 Bone Marrow Transplant. pmid:11571519
Coley KC et al. Lack of tacrolimus-induced cardiomyopathy. 2001 Ann Pharmacother pmid:11573873
Gingras AC et al. Control of translation by the target of rapamycin proteins. 2001 Prog. Mol. Subcell. Biol. pmid:11575159
Dumont FJ Treatment of transplant rejection: are the traditional immunosuppressants good enough? 2001 Curr Opin Investig Drugs pmid:11575705
Fujimoto H et al. Immunomodulatory constituents from an Ascomycete, Eupenicillium crustaceum, and revised absolute structure of macrophorin D. 2001 J. Nat. Prod. pmid:11575965
Bayle F [Focus on Islets of Langerhans transplantation]. 2001 Presse Med pmid:11577579
Thervet E [Minimization of immunosuppression]. 2001 Presse Med pmid:11577589
Oettinger-Barak O et al. Periodontal changes in liver cirrhosis and post-transplantation patients. I: clinical findings. 2001 J. Periodontol. pmid:11577956
Lawrence MC et al. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. 2001 Mol. Endocrinol. pmid:11579208
Al-Uzri A et al. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). 2001 Transplantation pmid:11579294
Mourad G et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. 2001 Transplantation pmid:11579299
Staatz CE et al. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. 2001 Transplantation pmid:11579300
Selzner N et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. 2001 Transplantation pmid:11579301
Savoldo B et al. Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. 2001 Transplantation pmid:11579304
Jain A et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. 2001 Transplantation pmid:11579306
Sloper CM et al. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. 2001 Ophthalmology pmid:11581059
Simpson D New developments in the prophylaxis and treatment of graft versus host disease. 2001 Expert Opin Pharmacother pmid:11583062
Assmann T et al. Topical tacrolimus for the treatment of inflammatory skin diseases. 2001 Expert Opin Pharmacother pmid:11583067
Ichimaru N et al. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. 2001 Atherosclerosis pmid:11583721
Hricik DE Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11583939
Pescovitz MD and Govani M Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients. 2001 Am. J. Kidney Dis. pmid:11583940
First MR Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. 2001 Transplantation pmid:11585240
Koomans HA and Ligtenberg G Mechanisms and consequences of arterial hypertension after renal transplantation. 2001 Transplantation pmid:11585243
Patel S et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. 2001 J. Bone Miner. Res. pmid:11585351
Chau TN et al. Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation. 2001 Liver pmid:11589769
Sezen SF et al. Immunophilin ligand FK506 is neuroprotective for penile innervation. 2001 Nat. Med. pmid:11590407
Morissette P et al. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. 2001 Ther Drug Monit pmid:11591897
Naka Y et al. Effects of dexamethasone and FK506 on Helicobacter pylori-induced gastritis and bacterial viability in Mongolian gerbils. 2001 Jan-Dec J. Physiol. Paris pmid:11595473
Dipchand AI et al. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil. 2001 J. Heart Lung Transplant. pmid:11595558
Christ B et al. Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. 2001 Urology pmid:11597545
Bultynck G et al. The conserved sites for the FK506-binding proteins in ryanodine receptors and inositol 1,4,5-trisphosphate receptors are structurally and functionally different. 2001 J. Biol. Chem. pmid:11598113
Hardinger KL et al. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. 2001 Surgery pmid:11602906
Dello Strologo L et al. Renal hemodynamic effect of tacrolimus in renal transplanted children. 2001 Pediatr. Nephrol. pmid:11605779
Serrano AL et al. Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11606756
Bornhövd E et al. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases. 2001 J. Am. Acad. Dermatol. pmid:11606925
Wang M et al. Inhibition of nitric oxide synthase induces intestinal mucosal damage and increases mortality in rats treated by FK506. 2001 Exp. Toxicol. Pathol. pmid:11665854
Fernández-Miranda C et al. Determinants of increased plasma homocysteine in 221 stable liver transplant patients. 2001 Clin. Chem. pmid:11673376
Carreras CW et al. An FKBP12 binding assay based upon biotinylated FKBP12. 2001 Anal. Biochem. pmid:11673895
Mimura T et al. [Treatment of steroid-resistant polymyositis and dermatomyositis]. 2001 Nippon Rinsho pmid:11676154
Kimikawa M et al. Effective oral administration of tacrolimus in renal transplant recipients. 2001 Clin Transplant pmid:11678958
Chisholm MA et al. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. 2001 Clin Transplant pmid:11678959
Arii T et al. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. 2001 Neurol. Res. pmid:11680517
Sakuma Y et al. High-dose tacrolimus and lengthy survival of the combined rat pancreas/spleen graft in a high-responder combination. 2001 Transpl. Immunol. pmid:11680570
Deters M et al. Comparative study analyzing effects of sirolimus-cyclosporin and sirolimus-tacrolimus combinations on bile flow in the rat. 2001 Dig. Dis. Sci. pmid:11680585
Onoe H et al. [Interaction of immunophilin FKBP and intracellular Ca2+ release channels]. 2001 Fukuoka Igaku Zasshi pmid:11681278
Suehiro E et al. The immunophilin ligand FK506 attenuates the axonal damage associated with rapid rewarming following posttraumatic hypothermia. 2001 Exp. Neurol. pmid:11681852
Dietemann J et al. Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus. 2001 Nephrol. Dial. Transplant. pmid:11682676
Barri YM et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. 2001 Clin Transplant pmid:11683817
Baan CC et al. Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression. 2001 Clin Transplant pmid:11683823
Geba GP et al. Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity. 2001 Immunology pmid:11683964
Ovuworie CA et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. 2001 Transplantation pmid:11685108
Oz HS et al. Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on pneumonitis in contrast to the anti- pneumonitis effects of mycophenolate mofetil. 2001 Transplantation pmid:11685124
Mazariegos GV et al. Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients. 2001 Paediatr Drugs pmid:11688597
Tucker CL and Fields S A yeast sensor of ligand binding. 2001 Nat. Biotechnol. pmid:11689849